American International Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-15,431
| Closed | -$183K | – | 1389 |
|
2024
Q1 | $183K | Buy |
15,431
+42
| +0.3% | +$498 | ﹤0.01% | 2198 |
|
2023
Q4 | $189K | Buy |
15,389
+3,099
| +25% | +$38K | ﹤0.01% | 2203 |
|
2023
Q3 | $118K | Buy |
12,290
+437
| +4% | +$4.21K | ﹤0.01% | 2414 |
|
2023
Q2 | $107K | Buy |
11,853
+39
| +0.3% | +$351 | ﹤0.01% | 2534 |
|
2023
Q1 | $92.9K | Buy |
11,814
+235
| +2% | +$1.85K | ﹤0.01% | 2491 |
|
2022
Q4 | $78.3K | Sell |
11,579
-42
| -0.4% | -$284 | ﹤0.01% | 2611 |
|
2022
Q3 | $169K | Buy |
11,621
+165
| +1% | +$2.4K | ﹤0.01% | 2255 |
|
2022
Q2 | $113K | Buy |
11,456
+337
| +3% | +$3.32K | ﹤0.01% | 2528 |
|
2022
Q1 | $164K | Sell |
11,119
-782
| -7% | -$11.5K | ﹤0.01% | 2361 |
|
2021
Q4 | $157K | Buy |
11,901
+1,021
| +9% | +$13.5K | ﹤0.01% | 2502 |
|
2021
Q3 | $190K | Sell |
10,880
-259
| -2% | -$4.52K | ﹤0.01% | 2459 |
|
2021
Q2 | $267 | Buy |
11,139
+34
| +0.3% | +$1 | ﹤0.01% | 2325 |
|
2021
Q1 | $285 | Buy |
11,105
+2,619
| +31% | +$67 | ﹤0.01% | 2167 |
|
2020
Q4 | $161 | Buy |
8,486
+332
| +4% | +$6 | ﹤0.01% | 2392 |
|
2020
Q3 | $103K | Sell |
8,154
-186
| -2% | -$2.35K | ﹤0.01% | 2523 |
|
2020
Q2 | $101K | Buy |
8,340
+868
| +12% | +$10.5K | ﹤0.01% | 2533 |
|
2020
Q1 | $57K | Sell |
7,472
-431
| -5% | -$3.29K | ﹤0.01% | 2615 |
|
2019
Q4 | $141K | Buy |
7,903
+532
| +7% | +$9.49K | ﹤0.01% | 2428 |
|
2019
Q3 | $86K | Sell |
7,371
-50
| -0.7% | -$583 | ﹤0.01% | 2696 |
|
2019
Q2 | $164K | Buy |
+7,421
| New | +$164K | ﹤0.01% | 2362 |
|
2016
Q2 | – | Sell |
-513
| Closed | -$5K | – | 3830 |
|
2016
Q1 | $5K | Hold |
513
| – | – | ﹤0.01% | 4727 |
|
2015
Q4 | $26K | Sell |
513
-1
| -0.2% | -$51 | ﹤0.01% | 4183 |
|
2015
Q3 | $26K | Hold |
514
| – | – | ﹤0.01% | 4184 |
|
2015
Q2 | $51.4K | Buy |
+514
| New | +$51.4K | ﹤0.01% | 4037 |
|